ROS-Responsive RNA Coacervates for Oxidative Stress-Triggered Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing RNA-based therapeutic delivery methods face challenges such as rapid degradation, inefficient cellular uptake, poor stability, and off-target effects, necessitating improved specificity and controlled release mechanisms.
Innovation Solution
Development of ROS-responsive RNA/spermine coacervates modified with DTSSP, which trigger controlled RNA release in response to elevated oxidative stress levels, utilizing spermine's modification with 3,3′-dithiobis(sulfosuccinimidyl propionate) to enhance specificity and targeted delivery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional RNA delivery methods are used, then RNA molecules can be delivered to cells, but rapid degradation by enzymes occurs and stability during circulation is poor
Solution Approach 1:
The patent uses complex coacervates formed by spermine and RNA as an intermediary delivery vehicle. The coacervate structure protects RNA from enzymatic degradation during circulation while maintaining stability, and enables controlled release at the target site through ROS-responsive mechanisms.
Solution Approach 2:
The patent modifies spermine with DTSSP to create ROS-responsive coacervates that change their structural parameters in response to reactive oxygen species. This parameter change enables the coacervates to transition from a stable encapsulated state during circulation to a released state at the target site with elevated ROS levels.
2Productivity
If conventional RNA delivery methods are used, then RNA can be transported into cells, but cellular uptake efficiency is poor
Solution Approach 1:
The patent creates composite coacervate structures combining spermine (a natural polycation) with RNA molecules. This composite material exhibits enhanced cellular uptake properties compared to naked RNA, while maintaining biocompatibility and controlled release capabilities through the polycation-polyanion complex structure.
3Reliability
If conventional RNA delivery methods are used, then RNA therapy can be administered, but off-target effects occur leading to unintended protein expression
Solution Approach 1:
The patent exploits the harmful factor of elevated ROS levels at disease sites (such as tumors with high oxidative stress) and converts it into a beneficial trigger for controlled RNA release. The DTSSP-modified spermine coacervates remain stable in normal conditions but disassemble specifically in high-ROS environments, enabling targeted delivery and minimizing off-target effects.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The ROS-responsive coacervates provide precise RNA delivery to cells with heightened oxidative stress, minimizing off-target effects and enhancing therapeutic efficacy by ensuring RNA release only at targeted sites.
Implementation Method 1
modifying the polycationic component of RNA complex coacervates to induce stimuli-triggered structural changes that release RNA molecules in response to elevated oxidative stress
Implementation Method 2
Complex coacervation is a phase separation process driven by oppositely charged polyelectrolytes that spontaneously form dense liquid-liquid aggregates
Implementation Method 3
These electrostatic interactions between spermine and RNA play a pivotal role in effectively encapsulating and safeguarding the RNA molecules during coacervation
Data Source
AI summary
Disclosed herein are novel and advanced technique for the modification of complex coacervates to induce structural changes releasing ribonucleic acid (RNA)-based molecules in response to oxidative stress. This approach leverages the reactivity of reactive oxygen species (ROS) generated during oxidative stress to trigger structural changes in the modified cationic coacervate component that induces phase miscibility and subsequently releases RNA molecules from the coacervate matrix.


